Appreciate the sentiments and you clearly have an understanding of the background and work it has taken to get NEU to this point but without meaning any disrespect I completely disagree that “FDA approval is hardly an issue here” or for that matter that significant patience is required with respect to share price.
FDA approval is a massive issue here - the most important event this company has faced to date IMO. As has been discussed here recently highly likely but by no means a certainty. With FDA approval NEU is an income generating cash cow with 4 phase 2 trials cooking away and becomes a massive takeover target before or after those phase 2 results are known. Share price given FDA approval has to be north of $12 I believe and will likely rise through 2023. Without FDA approval NEU has significant funding issues again, 4 phase 2 trials that wouldn’t look anywhere near as promising with an unproven drug 5+ years from commercialisation and a share price of (I’m guessing) approximately $1.
All of which is going to unfold in the next 40 trading days if not before. Any chance you could explain how you could possibly think otherwise??
- Forums
- ASX - By Stock
- NEU
- Share Price
Share Price, page-3198
-
-
- There are more pages in this discussion • 8,280 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
|
|||||
Last
$15.34 |
Change
-0.410(2.60%) |
Mkt cap ! $1.960B |
Open | High | Low | Value | Volume |
$15.88 | $15.93 | $15.34 | $6.463M | 415.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 6044 | $15.32 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$15.57 | 1411 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1892 | 15.320 |
3 | 2996 | 15.300 |
1 | 1308 | 15.290 |
1 | 300 | 15.280 |
2 | 1892 | 15.270 |
Price($) | Vol. | No. |
---|---|---|
15.570 | 1411 | 2 |
15.620 | 2616 | 3 |
15.660 | 1892 | 1 |
15.680 | 1892 | 1 |
15.710 | 1892 | 1 |
Last trade - 16.10pm 28/08/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
HAR
HARANGA RESOURCES LIMITED.
Peter Batten, MD
Peter Batten
MD
Previous Video
Next Video
SPONSORED BY The Market Online